The role of pathogenic B-cell clones in antibody mediated autoimmune disorders

Journal of Dermatological Science

Volumn 36, Issue 3, 2004, Pages 141-148

  Wang, Jing ^a   Zhu, Xuejun ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Autoimmune; B cell; Pathogenesis; Treatment

Indexed keywords

AUTOANTIBODY; CD20 ANTIBODY; CORTICOSTEROID; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DESMOGLEIN 3; FAS ANTIGEN; FAS LIGAND; GLUTAMATE DECARBOXYLASE; GLUTAMIC ACID DECARBOXYLASE[524-543]; IMMUNOGLOBULIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G ANTIBODY; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; IODINE 131; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CD 22; MONOCLONAL ANTIBODY CD 95; MONOCLONAL ANTIBODY CD19; RECOMBINANT ACETYLCHOLINE RECEPTOR; RECOMBINANT PROTEIN; RITUXIMAB; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; YTTRIUM 90;

ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; APOPTOSIS; AUTOIMMUNE DISEASE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL ADHESION; CELL FUNCTION; CELLULAR IMMUNITY; CHRONIC LYMPHATIC LEUKEMIA; CYTOKINE RELEASE; CYTOPENIA; DESMOSOME; DRUG TARGETING; ENDOPLASMIC RETICULUM; ENTERITIS; FLOW CYTOMETRY; HUMAN; IMMUNOTHERAPY; KERATINOCYTE; MOLECULAR CLONING; MONOCYTE; MULTIPLE MYELOMA; MYASTHENIA GRAVIS; NONHODGKIN LYMPHOMA; NONHUMAN; PATHOGENESIS; PATIENT; PEMPHIGOID; PEMPHIGUS; PEMPHIGUS VULGARIS; PLASMAPHERESIS; PRIORITY JOURNAL; RADIOIMMUNOTHERAPY; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; THROMBOCYTOPENIA; WESTERN BLOTTING;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CLONE CELLS; HUMANS;

EID: 8444246046     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2004.07.004     Document Type: Review

References (59)

1. L. Wang, D. Bu, Y. Yang, X. Chen, and X. Zhu Castleman's tumours and production of autoantibody in paraneoplastic pemphigus Lancet 363 2004 525 531
2. G.J. Anhalt, S.C. Kim, J.R. Stanley, N.J. Korman, D.A. Jabs, and M. Kory Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated with neoplasia N Engl J Med 323 1990 1729 1735
3. T.N. Helm, C. Camisa, A.Y. Liu, R. Valenzuela, and W.F. Bergfeld Lichen planus associated with neoplasia: a cell-mediated immune response to tumor antigens? J Am Acad Dermatol 30 1994 219 224
4. G.J. Anhalt Paraneoplastic pemphigus Adv Dermatol 12 1997 77 96 Discussion 97
5. G.M. Bowen, N.T. Peters, D.P. Fivenson, L.D. Su, H.C. Nousari, and G.J. Anhalt Lichenoid dermatitis in paraneoplastic pemphigus: a pathogenic trigger of epitope spreading? Arch Dermatol 136 2000 652 656
6. M. Amagai, T. Nishikawa, H.C. Nousari, G.J. Anhalt, and T. Hashimoto Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice J Clin Invest 102 1998 775 782
7. L.C. Wang, D.F. Bu, X.X. Chen, and X.J. Zhu The pathogenesis of paraneoplastic pemphigus associated with Castleman's disease Chin J Dermatol 37 2004 37 39
8. S.E. Kornguth Neuronal proteins and paraneoplastic syndromes N Engl J Med 321 1989 1607 1608
9. J.M. Weinstein, S.E. Kelman, G.H. Bresnick, and S.E. Kornguth Paraneoplastic retinopathy associated with antiretinal bipolar cell antibodies in cutaneous malignant melanoma Ophthalmology 101 1994 1236 1243
10. J.C. Antoine Immunological mechanisms in paraneoplastic peripheral neuropathy Clin Rev Allergy Immunol 19 2000 61 72
11. M. Noguchi, K. Mori, S. Yamazaki, K. Suda, N. Sato, and K. Oshimi Multifocal motor neuropathy caused by a B-cell lymphoma producing a monoclonal IgM autoantibody against peripheral nerve myelin glycolipids GM1 and GD1b Br J Haematol 123 2003 600 605
12. S. Ruzickova, A. Pruss, M. Odendahl, K. Wolbart, G.R. Burmester, and J. Scholze Chronic lymphocytic leukemia preceded by cold agglutinin disease: intraclonal immunoglobulin light-chain diversity in V(H)4-34 expressing single leukemic B-cells Blood 100 2002 3419 3422
13. K. Nishifuji, M. Amagai, M. Kuwana, T. Iwasaki, and T. Nishikawa Detection of antigen-specific B cellB-cells in patients with pemphigus vulgaris by enzyme-linked immunospot assay: requirement of T cell collaboration for autoantibody production J Invest Dermatol 114 2000 88 94
14. H. Leyendeckers, K. Tasanen, L. Bruckner-Tuderman, D. Zillikens, C. Sitaru, J. Schmitz, and N. Hunzelmann Memory B-cells specific for the NC16A domain of the 180 kDa bullous pemphigoid autoantigen can be detected in peripheral blood of bullous pemphigoid patients and induced in vitro to synthesize autoantibodies J Invest Dermatol 120 2003 372 378
15. T. Dorner, and G.R. Burmester The role of B-cells in rheumatoid arthritis: mechanisms and therapeutic targets Curr Opin Rheumatol 15 2003 246 252
16. H. Ohmori, and N. Kanayama Mechanisms leading to autoantibody production: link between inflammation and autoimmunity Curr Drug Targets Inflamm Allergy 2 2003 232 241
17. B. Rapoport, and S.M. McLachlan Thyroid autoimmunity J Clin Invest 108 2001 1253 1259
18. J.C. Jaume, S. Portolano, B. Rapoport, and S.M. McLachlan Influence of the light chain repertoire on immunoglobulin genes encoding thyroid autoantibody Fab from combinatorial libraries Autoimmunity 24 1996 11 23
19. K. Steinbrink, and J. Knop Significance of immunologic tolerance in dermatology Hautarzt 54 2003 45 52
20. N.A. Granholm, and T. Cavallo Autoimmunity, polyclonal B-cell activation and infection Lupus 1 1992 63 74
21. S.M. Friedman, D.N. Posnett, J.R. Tumang, B.C. Cole, and M.K. Crow A potential role for microbial superantigens in the pathogenesis of systemic autoimmune disease Arthritis Rheum 34 1991 468 480
22. L.E. Schiffer, N. Hussain, X. Wang, W. Huang, J. Sinha, and M. Ramanujam Lowering anti-dsDNA antibodies - what's new? Lupus 11 2002 885 894
23. T. Kato Analysis of B-cell autoepitopes and mechanisms for autoantibody production in autoimmune diseases Nippon Rinsho 55 1997 1462 1467
24. F. Tron, S. Jacquot, and D. Gilbert B-cell anomalies in systemic lupus erythematosus Ann Med Interne (Paris) 153 2002 503 512
25. C.J. Chapman, M.B. Spellerberg, G.A. Smith, S.J. Carter, T.J. Hamblin, and F.K. Stevenson Autoanti-red cell antibodies synthesized by patients with infectious mononucleosis utilize the VH4-21 gene segment J Immunol 151 1993 1051 1061
26. M. Zouali B-cell diversity and longevity in systemic autoimmunity Mol Immunol 38 2002 895 901
27. B.A. Jacobson, T.L. Rothstein, and A. Marshak-Rothstein The role of Fas/FasL interactions in the regulation of B-cell function Behring Inst Mitt 1996 185 199
28. P. Rieckmann, J.M. Tuscano, and J.H. Kehrl Tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in B-lymphocyte function Methods 11 1997 128 132
29. S. Fillatreau, C.H. Sweenie, M.J. McGeachy, D. Gray, and S.M. Anderton B-cells regulate autoimmunity by provision of IL-10 Nat Immunol 3 2002 944 950
30. J.J. O'Shea, A. Ma, and P. Lipsky Cytokines and autoimmunity Nat Rev Immunol 2 2002 37 45
31. R.H. Carter, Y. Wang, and S. Brooks Role of CD19 signal transduction in B-cell biology Immunol Res 26 2002 45 54
32. R.K. Do, and S. Chen-Kiang Mechanism of BLyS action in B-cell immunity Cytokine Growth Factor Rev 13 2002 19 25
33. F. Mackay, S.A. Woodcock, P. Lawton, C. Ambrose, M. Baetscher, and P. Schneider Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations J Exp Med 190 1999 1697 1710
34. S. Sato, M. Hasegawa, M. Fujimoto, T.F. Tedder, and K. Takehara Quantitative genetic variation in CD19 expression correlates with autoimmunity J Immunol 165 2000 6635 6643
35. D.T. Fearon, and M.C. Carroll Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex Annu Rev Immunol 18 2000 393 422
36. C. Larroche, Y. Chanseaud, P. Garcia de la Pena-Lefebvre, and L. Mouthon Mechanisms of intravenous immunoglobulin action in the treatment of autoimmune disorders BioDrugs 16 2002 47 55
37. J. Bayry, S. Lacroix-Desmazes, S. Delignat, L. Mouthon, B. Weill, and M.D. Kazatchkine Intravenous immunoglobulin abrogates dendritic cell differentiation induced by interferon-alpha present in serum from patients with systemic lupus erythematosus Arthritis Rheum 48 2003 3497 3502
38. J. Bayry, N. Misra, V. Latry, F. Prost, S. Delignat, and S. Lacroix-Desmazes Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases Transfus Clin Biol 10 2003 165 169
39. K.Y. Fong Immunotherapy in autoimmune diseases Ann Acad Med Singapore 31 2002 702 706
40. Y. Cohen, and A. Nagler Treatment of refractory autoimmune diseases with lymphoablation and hematopoietic stem cell support Isr Med Assoc J 4 2002 865 867
41. F. Zaja, N. Vianelli, A. Sperotto, F. Patriarca, M. Tani, and L. Marin Anti-CD20 therapy for chronic lymphocytic leukemia-associated autoimmune diseases Leuk Lymphoma 44 2003 1951 1955
42. F. Zaja, N. Vianelli, A. Sperotto, S. De Vita, I. Iacona, and A. Zaccaria B-cell compartment as the selective target for the treatment of immune thrombocytopenias Haematologica 88 2003 538 546
43. F. Zaja, I. Iacona, P. Masolini, D. Russo, A. Sperotto, and S. Prosdocimo B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia Haematologica 87 2002 189 195
44. G.J. Silverman, and S. Weisman Rituximab therapy and autoimmune disorders: prospects for anti-B-cell therapy Arthritis Rheum 48 2003 1484 1492
45. A. Bosly, M.J. Keating, R. Stasi, and K. Bradstock Rituximab in B-cell disorders other than non-Hodgkin's lymphoma Anticancer Drugs 13 Suppl. 2 2002 25 33
46. N.E. Benoit, and W.F. Wade Increased inhibition of proliferation of human B-cell lymphomas following ligation of CD40, and either CD19, CD20 CD95 or surface immunoglobulin Immunopharmacology 35 1996 129 139
47. P.C. Taylor Antibody therapy for rheumatoid arthritis Curr Opin Pharmacol 3 2003 323 328
48. E. Andreakos, P.C. Taylor, and M. Feldmann Monoclonal antibodies in immune and inflammatory diseases Curr Opin Biotechnol 13 2002 615 620
49. J. Tian, A. Olcott, L. Hanssen, D. Zekzer, and D.L. Kaufman Antigen-based immunotherapy for autoimmune disease: from animal models to humans? Immunol Today 20 1999 190 195
50. G.T. Nepom Therapy of autoimmune diseases: clinical trials and new biologics Curr Opin Immunol 14 2002 812 815
51. I. Krause, M. Blank, and Y. Shoenfeld Peptide immunotherapy in autoimmune diseases Drug News Persp 13 2000 78 84
52. J.P. Revillard Mechanisms of autoimmunity and therapeutic implications Rev Prat 51 2001 1528 1533
53. J.P. Revillard Recent advances in physiopathology of autoimmune diseases and their therapeutic implications Pediatrie 48 1993 759 769
54. M.D. Kazatchkine, and A. Coutinho Are lymphocytes concerned with our definition of idiotypes? Immunol Today 14 1993 513 515
55. B. Sulzer, and J.L. Hemmen Adaptive control: a strategy to treat autoimmunity J Theor Biol 196 1999 73 79
56. M. Wu Are immunoconjugates useful for therapy with autoimmune diseases? Int J Immunopharmacol 19 1997 83 93
57. C. Yeadon, and J. Karsh Lymphapheresis in rheumatoid arthritis: the clinical and laboratory effects of a limited course of cell depletion Clin Exp Rheumatol 1 1983 119 124
58. F. Perosa, G. Luccarelli, M. Prete, and F. Dammacco Monoclonal antibodies in the immunotherapy of autoimmune diseases Ann Ital Med Int 16 2001 220 232
59. W. Magliani, S. Conti, A. Salati, S. Arseni, L. Ravanetti, and R. Frazzi Biotechnological approaches to the production of idiotypic vaccines and antiidiotypic antibiotics Curr Pharm Biotechnol 4 2003 91 97